---
category: news
title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"
excerpt: "“As each patient’s cancer is unique, we have developed a therapy that turns their ... from its world-leading expertise in artificial intelligence and its unique algorithm that is used to ..."
publishedDateTime: 2020-01-07T00:12:00Z
webUrl: "https://www.businesswire.com/news/home/20200106006021/en/Transgene-NEC-Start-Clinical-Trials-TG4050-AI-Powered"
type: article
quality: 14
heat: 14
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI
  - AI in Healthcare

images:
  - url: "https://mms.businesswire.com/media/20200106006021/en/765262/23/NEC.jpg"
    width: 1200
    height: 627
    title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"

secured: "ulU3o2uakMXfDrZuZpqQ1JZj86Qc6d6e0OX4zzYxzeQCn80WA05JQerJPVwjaSZuO+h5A1UKixOvZXj8MEMP2wx+1kWs0ZomaGQwHNw/1CYK42Qfbt9FPOocSTowX8hykaRooNhPI0y4zESJm9naGmUX9IOCYU/VWn5IaymVfLSxW2nz1IIbXIjaa8yN0fRIOZiV0sFpcG+D5LsSamBvy6l3xM5jBDuIkzzHQKv/uDuQvkWze2WYMqcSmr/vPaStf03eV/QpxMCt14yLQi6/sBy5sk1EioEByAQIPYyxEwk1FDUBqgqNaS7pisrrxGLz;S8TZeyWUczIn9C7fXCix6g=="
---

